Legal Experts Provide Updates on Biosimilar Patent Disputes in 2022
Patent litigators from Fish & Richardson, an intellectual house regulation company, regaled audiences throughout a webinar, entitled “Biosimilars: 2022 Yr-in-Evaluation,” covering all the major biosimilar regulatory and authorized selections through 2022, including updates on patent disputes and anti-believe in investigations. Approvals and Launches Jenny Shmuel, JD, principal at Fish & Richardson, delivered an ignore of…